Hans Hoerauf
Research Subjects
Hans Hoerauf has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Horst Laqua
University Eye Clinic Lübeck
5 shared publicationsDirk-Henning Menz
Pharmpur GmbH, Koenigsbrunn, Germany
3 shared publicationsJoachim Dresp
Feldbergstr. 58a, Muenchen, Germany
3 shared publicationsNicolas Feltgen
Department of Ophthalmology, University Medical Center, Goettingen, Germany
3 shared publicationsReginald Birngruber
Medical Laser Center, Peter‐Monnik‐Weg 4, 23532 Luebeck, Germany
3 shared publicationsBernd-Kristof Müller
Pharmpur GmbH, Koenigsbrunn, Germany
2 shared publications
Latest Publications
- Open Access
- 1 May 2019
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 8 (3) , 24
Hydrofluoric Acid and Other Impurities in Toxic Perfluorooctane Batches
Purpose: The complications with cytotoxic perfluorooctane (PFO) batches reported in 2015 were attributed to reactive underfluorinated impurities whose chemical identity and behavior still need to be clarified. Material and Methods: We analyzed original packaged samples of Ala®octa batches involved in several reported cases of retinal toxicity. (A) The impurity profile was determined. (B) pH and fluoride ion content were measured. (C) Extraction with olive oil was performed to investigate differences in lipophilia among perfluorinated liquid (PFCL) as a measure for penetration of lipophilic cell membranes followed by measurements (A) and (B). Results: (A) The detected impurities can be divided into: (1) reactive underfluorinated compounds and their degradation products including hydrogen fluoride (HF), (2) nonreactive underfluorinated compounds, (3) surface active compounds, (4) nonreactive fluorinated compounds, and (5) leachables from primary packaging components. The highest acute toxic potential is associated with the impurities of group (1). (B) HF was detected as a degradation product of reactive underfluorinated impurities by relying on the pH values and fluoride ion content of the water extracts. (C) Lipophilic impurities dissolved in PFO migrate into lipophilic extraction medium. In particular, HF is rapidly transferred in this way. Conclusions: HF as degradation product of unstable or reactive underfluorinated contaminants seems of particular importance triggering the acute toxicity of affected PFO. Contamination related toxicity and unwanted side effects can only be reliably excluded via analytical controlled multistage, high-purification processes. Translational Relevance: In Ala®octa batches different impurities show retinal toxicity. HF seems of particular importance of the acute toxicity of PFO.
- 1 May 2019
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 8 (3) , 24
Open AccessHydrofluoric Acid and Other Impurities in Toxic Perfluorooctane Batches
Purpose: The complications with cytotoxic perfluorooctane (PFO) batches reported in 2015 were attributed to reactive underfluorinated impurities whose chemical identity and behavior still need to be clarified. Material and Methods: We analyzed original packaged samples of Ala®octa batches involved in several reported cases of retinal toxicity. (A) The impurity profile was determined. (B) pH and fluoride ion content were measured. (C) Extraction with olive oil was performed to investigate differences in lipophilia among perfluorinated liquid (PFCL) as a measure for penetration of lipophilic cell membranes followed by measurements (A) and (B). Results: (A) The detected impurities can be divided into: (1) reactive underfluorinated compounds and their degradation products including hydrogen fluoride (HF), (2) nonreactive underfluorinated compounds, (3) surface active compounds, (4) nonreactive fluorinated compounds, and (5) leachables from primary packaging components. The highest acute toxic potential is associated with the impurities of group (1). (B) HF was detected as a degradation product of reactive underfluorinated impurities by relying on the pH values and fluoride ion content of the water extracts. (C) Lipophilic impurities dissolved in PFO migrate into lipophilic extraction medium. In particular, HF is rapidly transferred in this way. Conclusions: HF as degradation product of unstable or reactive underfluorinated contaminants seems of particular importance triggering the acute toxicity of affected PFO. Contamination related toxicity and unwanted side effects can only be reliably excluded via analytical controlled multistage, high-purification processes. Translational Relevance: In Ala®octa batches different impurities show retinal toxicity. HF seems of particular importance of the acute toxicity of PFO.
- Open Access
- 1 October 2018
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 59 (12) , 4841-4846
How to Ward Off Retinal Toxicity of Perfluorooctane and Other Perfluorocarbon Liquids?
Purpose: Reactive and underfluorinated impurities are acknowledged as a source of cytotoxicity of perfluorocarbon liquids (PFCLs) used as blood substitutes. To determine whether this is also a relevant factor in retinal toxicity, we analyzed eight PFO batches associated with adverse ocular events. Methods: (A) The amount of reactive and underflurinated impurities was analyzed by fluoride-selective potentiometry and expressed as H-value. (B) Cytotoxicity of these batches was determined by an ISO 10993-5-compliant extractive test and compared to published data generated with a direct-contact method. (C) A toxic PFO batch (061014) was purified to remove reactive and underfluorinated impurities. (A) and (B) -measurements were repeated after that. (D) The dose dependence of the H-value and cytotoxicity was determined in a dilution experiment. Results: (A) The batches revealed H-values ranging from 1.400 ppm to 4.500 ppm. (B) All batches induced cell growth inhibition; seven must be classified as cytotoxic. Findings from ISO-conform extractive and direct-contact methods showed no difference. (C) After all reactive and underfluorinated impurities in batch 061014 were removed, the H-value dropped to Conclusions: The clinical relevance of the H-value as a safety parameter for PFO endotamponades could be proven. The H-value is a measure for reactive and underfluorinated impurities that cause toxicity of PFCLs and should be incorporated in each endotamponade specification with a limit of 10 ppm to prove the effectiveness of the ultra-purification required and ensure a safe product. Despite the fact that an (ISO)-standard literally is a “standard” only, which cannot cover all imaginable possibilities, the incorporation of the H-value determination into the relevant ISO standard has been initiated. If a thorough risk assessment results in risks that cannot be detected and/or managed by the effective standard, additional investigations have to be performed.
- 1 October 2018
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 59 (12) , 4841-4846
Open AccessHow to Ward Off Retinal Toxicity of Perfluorooctane and Other Perfluorocarbon Liquids?
Purpose: Reactive and underfluorinated impurities are acknowledged as a source of cytotoxicity of perfluorocarbon liquids (PFCLs) used as blood substitutes. To determine whether this is also a relevant factor in retinal toxicity, we analyzed eight PFO batches associated with adverse ocular events. Methods: (A) The amount of reactive and underflurinated impurities was analyzed by fluoride-selective potentiometry and expressed as H-value. (B) Cytotoxicity of these batches was determined by an ISO 10993-5-compliant extractive test and compared to published data generated with a direct-contact method. (C) A toxic PFO batch (061014) was purified to remove reactive and underfluorinated impurities. (A) and (B) -measurements were repeated after that. (D) The dose dependence of the H-value and cytotoxicity was determined in a dilution experiment. Results: (A) The batches revealed H-values ranging from 1.400 ppm to 4.500 ppm. (B) All batches induced cell growth inhibition; seven must be classified as cytotoxic. Findings from ISO-conform extractive and direct-contact methods showed no difference. (C) After all reactive and underfluorinated impurities in batch 061014 were removed, the H-value dropped to Conclusions: The clinical relevance of the H-value as a safety parameter for PFO endotamponades could be proven. The H-value is a measure for reactive and underfluorinated impurities that cause toxicity of PFCLs and should be incorporated in each endotamponade specification with a limit of 10 ppm to prove the effectiveness of the ultra-purification required and ensure a safe product. Despite the fact that an (ISO)-standard literally is a “standard” only, which cannot cover all imaginable possibilities, the incorporation of the H-value determination into the relevant ISO standard has been initiated. If a thorough risk assessment results in risks that cannot be detected and/or managed by the effective standard, additional investigations have to be performed.
- 15 August 2017
- Published by Springer Nature in Der Ophthalmologe
- Vol. 114 (11) , 1042-1049
„Zuwarten“ als therapeutisches Prinzip bei Erkrankungen der vitreoretinalen Grenzfläche
- 15 August 2017
- Published by Springer Nature in Der Ophthalmologe
- Vol. 114 (11) , 1042-1049
„Zuwarten“ als therapeutisches Prinzip bei Erkrankungen der vitreoretinalen Grenzfläche
- 1 September 2016
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 169, 258-267
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study
- 1 September 2016
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 169, 258-267
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study
- Open Access
- 30 June 2016
- Published by ClinMed International Library in International Journal of Pathology and Clinical Research
- Vol. 2 (2)
Atypical Retinal Arterial Macroaneurysm
A patient with an atypical retinal arterial macroaneurysm masked by a persistent vitreous haemorrhage mimicking a neoplasm is presented. During vitrectomy a pigmented peripapillary tumour located at large vessels with circinate lipid exsudates was detected. Examination of removed tissue revealed haemosiderin-loaded macrophages resulting in pigmentation. The histologic finding of phagocytosis of intraretinal blood remnants allowed to diagnose an atypical retinal arterial macroaneurysm.
- 30 June 2016
- Published by ClinMed International Library in International Journal of Pathology and Clinical Research
- Vol. 2 (2)
Open AccessAtypical Retinal Arterial Macroaneurysm
A patient with an atypical retinal arterial macroaneurysm masked by a persistent vitreous haemorrhage mimicking a neoplasm is presented. During vitrectomy a pigmented peripapillary tumour located at large vessels with circinate lipid exsudates was detected. Examination of removed tissue revealed haemosiderin-loaded macrophages resulting in pigmentation. The histologic finding of phagocytosis of intraretinal blood remnants allowed to diagnose an atypical retinal arterial macroaneurysm.
- 20 December 2007
- Published by Springer Nature in Der Ophthalmologe
- Vol. 105 (1) , 7-18
Skleraeindellende Ablatiochirurgie und pneumatische Retinopexie
- 20 December 2007
- Published by Springer Nature in Der Ophthalmologe
- Vol. 105 (1) , 7-18
Skleraeindellende Ablatiochirurgie und pneumatische Retinopexie
- 18 October 2007
- Published by BMJ in British Journal of Ophthalmology
- Vol. 91 (11) , 1415-1416
Predictive values in macular hole repair
Optical coherence tomography improves the management of persistent macular holes
- 18 October 2007
- Published by BMJ in British Journal of Ophthalmology
- Vol. 91 (11) , 1415-1416
Predictive values in macular hole repair
Optical coherence tomography improves the management of persistent macular holes
- 1 March 2007
- Published by Springer Nature in Der Ophthalmologe
- Vol. 104 (3) , 246-249
Netzhautblutung bei lachsfarbenen Gefäßen
- 1 March 2007
- Published by Springer Nature in Der Ophthalmologe
- Vol. 104 (3) , 246-249
Netzhautblutung bei lachsfarbenen Gefäßen
- 17 November 2006
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 85 (1) , 114-116
Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma
- 17 November 2006
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 85 (1) , 114-116
Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma
- 28 September 2006
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 245 (3) , 385-390
Real-time imaging of transscleral diode laser cyclophotocoagulation by optical coherence tomography
To present optical coherence tomography (OCT) for real-time imaging of cyclophotocoagulation effects.
- 28 September 2006
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 245 (3) , 385-390
Real-time imaging of transscleral diode laser cyclophotocoagulation by optical coherence tomography
To present optical coherence tomography (OCT) for real-time imaging of cyclophotocoagulation effects.